CeriBell's AI-powered EEG system offers rapid seizure diagnosis. The stock is undervalued by at least 50% over the long-term, ...

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis.

New research identifies high-frequency oscillations as potential biomarkers in Alzheimer’s disease, revealing levetiracetam’s differential effects on epileptic and non-epileptic patients.

Starting today, the National Institute for Health and Care Excellence (NICE) has recommended the funding of fenfluramine for NHS patients in England. This new drug is specifically approved for ...

New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...

NaviFUS is Taiwan's first and only high-end medical device company leveraging advanced chip integration and chip deployment, cementing its leadership in the global market. As the demand for ...

A gene variant identified in a family and studied in a fruit fly model may offer protection against a rare X-linked seizure ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out on the NHS. Fenfluramine has been recommended by the National Institute for ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Southern Methodist University biology researchers are uncovering how brain, heart, and lung connections may hold the key to ...